Envista Holdings Corp
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Paul A. Keel
- Full Time Employees
- 12,300
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Address
- 200 S Kraemer Blvd Bldg E Brea CA United States of America 92821-6208
- IPO Date
- Sep 18, 2019
- CIK
- 0001757073
- Website
- envistaco.com
- Similar Companies
- Business
- Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.
NVST Stock Explained for 2026 Growth Drivers and Risks
Here's Why Envista (NVST) is a Strong Value Stock
Envista Holdings Corp (NVST) Shares Surge 3.1% -- What GF Score of 82 Tells Investors
Why Envista (NVST) is a Top Value Stock for the Long-Term
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
Envista Q1 Earnings Call Highlights
Envista (NVST) International Revenue Performance Explored
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista Reports First Quarter 2026 Results
Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST)
Envista Holdings Corporation $NVST Shares Purchased by Cwm LLC
Envista Schedules First Quarter 2026 Earnings Call
Here's Why Envista (NVST) is a Strong Value Stock
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista Stock Up 42.5% in a Year: What's Driving It?
NVST or SYK: Which Is the Better Value Stock Right Now?